Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, April 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 157 articles:
HTML format


 

Single Articles

  1. GUO H, Yang S, Li S, Yan M, et al
    LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.
    Biomed Pharmacother. 2018;102:749-757.
    Abstract    

    Abstract available

  2. ZHANG H, Zhang Z, Wang S, Zhang S, et al
    The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.
    Biomed Pharmacother. 2018;102:626-632.
    Abstract    

    Abstract available

  3. SIGNORELLI M, Bogani G, Chiappa V, Ditto A, et al
    Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery: our experience and analysis of the literature.
    Minerva Ginecol. 2018 Mar 30. pii: S0026-4784.18.04221.
    Abstract    

    Abstract available

  4. ZHAI QL, Hu XD, Xiao J, Yu DQ, et al
    [Astragalus polysaccharide may increase sensitivity of cervical cancer HeLa cells to cisplatin by regulating cell autophagy].
    Zhongguo Zhong Yao Za Zhi. 2018;43:805-812.
    Abstract    

    Abstract available

  5. MORAVAC CC
    Reflections of Homeless Women and Women with Mental Health Challenges on Breast and Cervical Cancer Screening Decisions: Power, Trust, and Communication with Care Providers.
    Front Public Health. 2018;6:30.
    Abstract    

    Abstract available

  6. HOTA PK, Panda N, Nayak B, Samantaray S, et al
    Geographical distribution of cervical cancer in Odisha: A 5-year retrospective study at a regional cancer center.
    South Asian J Cancer. 2018;7:34-36.
    Abstract    

    Abstract available

  7. TRYBUS W, Krol T, Trybus E, Stachurska A, et al
    Induction of Mitotic Catastrophe in Human Cervical Cancer Cells After Administration of Aloe-emodin.
    Anticancer Res. 2018;38:2037-2044.
    Abstract    

    Abstract available

  8. DEGAREGE A, Krupp K, Fennie K, Li T, et al
    Urban-rural inequities in the parental attitudes and beliefs towards Human papillomavirus infection, cervical cancer and HPV vaccine in Mysore, India.
    J Pediatr Adolesc Gynecol. 2018 Mar 26. pii: S1083-3188(18)30185.
    Abstract    

    Abstract available

  9. IYER AL, Bundorf MK, Gyrd-Hansen D, Goldhaber-Fiebert JD, et al
    How does information on the harms and benefits of cervical cancer screening alter the intention to be screened?: a randomized survey of Norwegian women.
    Eur J Cancer Prev. 2018 Mar 27. doi: 10.1097/CEJ.0000000000000436.
    Abstract    

    Abstract available

  10. DING B, Sun W, Han S, Cai Y, et al
    Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e0210.
    Abstract    

    Abstract available

  11. LI F, Guo H, Qiu H, Liu S, et al
    Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer.
    Medicine (Baltimore). 2018;97:e0173.
    Abstract    

    Abstract available

  12. CARRASQUILLO O, Seay J, Amofah A, Pierre L, et al
    HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial.
    J Gen Intern Med. 2018 Mar 28. pii: 10.1007/s11606-018-4404.
    Abstract    

    Abstract available

  13. LIN CL, Lee CH, Chen CM, Cheng CW, et al
    Protodioscin Induces Apoptosis Through ROS-Mediated Endoplasmic Reticulum Stress via the JNK/p38 Activation Pathways in Human Cervical Cancer Cells.
    Cell Physiol Biochem. 2018;46:322-334.
    Abstract    

    Abstract available

  14. OLWANDA E, Shen J, Kahn JG, Bryant-Comstock K, et al
    Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study.
    Glob Health Action. 2018;11:1451455.
    Abstract    

    Abstract available

  15. FAVRE J, Rochoy M, Raginel T, Pelletier M, et al
    The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    J Womens Health (Larchmt). 2018 Mar 27. doi: 10.1089/jwh.2017.6656.
    Abstract    

    Abstract available

  16. NWABICHIE CC, Manaf RA, Ismail SB
    Factors Affecting Uptake of Cervical Cancer Screening Among African Women in Klang Valley, Malaysia
    Asian Pac J Cancer Prev. 2018;19:825-831.
    Abstract    

    Abstract available

  17. MALMIR S, Barati M, Khani Jeihooni A, Bashirian S, et al
    Effect of an Educational Intervention Based on Protection Motivation Theory on Preventing Cervical Cancer among Marginalized Women in West Iran
    Asian Pac J Cancer Prev. 2018;19:755-761.
    Abstract    

    Abstract available

  18. LIAN BSX, Yek AEH, Shuvas H, Abdul Rahman SF, et al
    Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines.
    BMC Res Notes. 2018;11:197.
    Abstract    

    Abstract available

  19. NGUYEN ND, Deshpande V, Luebeck J, Mischel PS, et al
    ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer.
    Nucleic Acids Res. 2018 Mar 20. pii: 4944397. doi: 10.1093.
    Abstract    

    Abstract available

  20. FANG JH, Yu XM, Zhang SH, Yang Y, et al
    Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
    J Cancer Res Ther. 2018;14.
    Abstract    

    Abstract available

  21. WANG Y, Kong W, Lv N, Li F, et al
    Incidence of radiation enteritis in cervical cancer patients treated with definitive radiotherapy versus adjuvant radiotherapy.
    J Cancer Res Ther. 2018;14.
    Abstract    

    Abstract available

  22. YANG S, Xing L, Gu L, Cheng H, et al
    Combination of RIZ1 Over-Expression and Radiotherapy Contributes to Apoptosis and DNA Damage of HeLa and SiHa Cervical Cancer Cells.
    Basic Clin Pharmacol Toxicol. 2018 Mar 25. doi: 10.1111/bcpt.13008.
    Abstract    

    Abstract available

  23. TAKEKUMA M, Shimokawa M, Nishio S, Omi H, et al
    A phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis.
    Cancer Sci. 2018 Mar 25. doi: 10.1111/cas.13577.
    Abstract    

    Abstract available

  24. LI GC, Cao XY, Li YN, Qiu YY, et al
    MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    J Cell Physiol. 2018 Mar 25. doi: 10.1002/jcp.26574.
    Abstract    

    Abstract available

  25. LADD IG, Gogoi RP, Bogaczyk TL, Larson SL, et al
    Cervical Cancer Patients' Willingness and Ability to Serve as Health Care Educators to Advocate for Human Papillomavirus Vaccine Uptake.
    J Cancer Educ. 2018 Mar 25. pii: 10.1007/s13187-018-1348.
    Abstract    

    Abstract available

  26. CHEN VE, Gillespie EF, Manger RP, Skerritt LA, et al
    The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer.
    Med Dosim. 2018 Mar 21. pii: S0958-3947(18)30028.
    Abstract    

    Abstract available

  27. BAO H, Zhang L, Wang L, Zhang M, et al
    Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.
    Cancer Med. 2018 Mar 24. doi: 10.1002/cam4.1321.
    Abstract    

    Abstract available

  28. ZHANG H, Liu C, Yan T, Wang J, et al
    Long noncoding RNA BDNF-AS is downregulated in cervical cancer and has anti-cancer functions by negatively associating with BDNF.
    Arch Biochem Biophys. 2018 Mar 20. pii: S0003-9861(18)30092.
    Abstract    

    Abstract available

  29. ZHANG Y, Cheng X, Liang H, Jin Z, et al
    Long non-coding RNA HOTAIR and STAT3 synergistically regulate the cervical cancer cell migration and invasion.
    Chem Biol Interact. 2018;286:106-110.
    Abstract    

    Abstract available

  30. DEMARCO M, Cheung LC, Kinney WK, Wentzensen N, et al
    Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
    J Low Genit Tract Dis. 2018;22:97-103.
    Abstract    

    Abstract available

  31. CASTLE P, Feldman S, Perkins RB
    The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?
    J Low Genit Tract Dis. 2018;22:91-96.
    Abstract    



  32. BOONE E, Karp M, Lewis L
    Ending Cervical Cancer Screening in Low-Risk Women After Age 65: Understanding Barriers to Adherence With Evidence-Based Guidelines Among Primary Care Providers.
    Health Serv Res Manag Epidemiol. 2018;5:2333392818755241.
    Abstract    

    Abstract available

  33. NAKAMURA H, Taguchi A, Kawana K, Baba S, et al
    Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
    Oncotarget. 2018;9:13451-13461.
    Abstract    

    Abstract available

  34. MOELLE U, Mathewos A, Aynalem A, Wondemagegnehu T, et al
    Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival.
    Oncologist. 2018 Mar 22. pii: theoncologist.2017-0271.
    Abstract    

    Abstract available

  35. JALIL EM, Luz PM, Quintana M, Friedman RK, et al
    Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.
    Braz J Infect Dis. 2018;22:16-23.
    Abstract    

    Abstract available

  36. FEMI OF
    Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States.
    Int J Health Sci (Qassim). 2018;12:28-32.
    Abstract    

    Abstract available

  37. SANG L, Wang X, Zhao X
    Mifepristone Inhibits the Migration of Cervical Cancer Cells by Inhibiting Exocrine Secretion.
    Pharmacology. 2018;101.
    Abstract    

    Abstract available

  38. WEI LC, Li X, Zhang Y, Dang YZ, et al
    Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer.
    Medicine (Baltimore). 2018;97:e0331.
    Abstract    

    Abstract available

  39. WU WJ, Shen Y, Sui J, Li CY, et al
    Integrated analysis of long noncoding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
    Mol Med Rep. 2018 Apr 5. doi: 10.3892/mmr.2018.8846.
    Abstract    

    Abstract available

  40. ANDREW M, Kim Y, Ginader T, Smith BJ, et al
    Reduction of applicator displacement in MR/CT-guided cervical cancer HDR brachytherapy by the use of patient hover transport system.
    J Contemp Brachytherapy. 2018;10:85-90.
    Abstract    

    Abstract available

  41. SUD S, Roth T, Jones E
    Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2018;10:32-39.
    Abstract    

    Abstract available

  42. DERKS K, Steenhuijsen JLG, van den Berg HA, Houterman S, et al
    Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer.
    J Contemp Brachytherapy. 2018;10:17-25.
    Abstract    

    Abstract available

  43. AKHTAR A, Wang SX, Ghali L, Bell C, et al
    Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  44. AGBO S, Bemanana HS, Aziagbenyo KM, Lahaye FM, et al
    Knowledge and practice of Togolese women concerning cervical cancer.
    Med Sante Trop. 2018;28:82-85.
    Abstract    

    Abstract available

  45. OCHS K, Meili G, Diebold J, Arndt V, et al
    Incidence Trends of Cervical Cancer and Its Precancerous Lesions in Women of Central Switzerland from 2000 until 2014.
    Front Med (Lausanne). 2018;5:58.
    Abstract    

    Abstract available

  46. BOURGIN C, Estevez JP, Collinet P
    [Post therapeutic cervical cancer surveillance in France: Priority for examination].
    Gynecol Obstet Fertil Senol. 2018 Mar 31. pii: S2468-7189(18)30081.
    Abstract    



  47. AKHTAR N, Pathak K
    Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
    Recent Pat Drug Deliv Formul. 2018 Apr 2. pii: DDF-EPUB-89468.
    Abstract    

    Abstract available

  48. MARQUINA G, Manzano A, Casado A
    Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
    Curr Oncol Rep. 2018;20:40.
    Abstract    

    Abstract available

  49. LI P, Guo H, Zhou G, Shi H, et al
    Increased ZNF84 expression in cervical cancer.
    Arch Gynecol Obstet. 2018 Apr 2. pii: 10.1007/s00404-018-4770.
    Abstract    

    Abstract available

  50. WANG S, Sun X, Cheng W, Zhang J, et al
    Pilot in vitro and in vivo study on a mouse model to evaluate the safety of transcutaneous low-frequency electrical nerve stimulation on cervical cancer patients.
    Int Urogynecol J. 2018 Apr 2. pii: 10.1007/s00192-018-3625.
    Abstract    

    Abstract available

  51. WANG Q, Xu H, Zhao X
    Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.
    Med Sci Monit. 2018;24:1955-1961.
    Abstract    

    Abstract available

  52. BRUM IV, Rodrigues TCGF, Laporte EGJ, Aarestrup FM, et al
    Does Knowing Someone with Breast Cancer Influence the Prevalence of Adherence to Breast and Cervical Cancer Screening?
    Rev Bras Ginecol Obstet. 2018 Apr 2. doi: 10.1055/s-0038-1623512.
    Abstract    

    Abstract available

  53. SHIN KJ, Ji YI
    Anti-Hu antibody-mediated limbic encephalitis associated with cervical cancer: A case report.
    J Obstet Gynaecol Res. 2018 Apr 2. doi: 10.1111/jog.13619.
    Abstract    

    Abstract available

  54. ODUNYEMI FT, Ndikom CM, Oluwatosin OA
    Effect of Nursing Intervention on Mothers' Knowledge of Cervical Cancer and Acceptance of Human Papillomavirus Vaccination for their Adolescent Daughters in Abuja - Nigeria.
    Asia Pac J Oncol Nurs. 2018;5:223-230.
    Abstract    

    Abstract available

  55. KAUR M, Agnihotri M, Das K, Rai B, et al
    Effectiveness of an Interventional Package on the Level of Anxiety, Depression, and Fatigue among Patients with Cervical Cancer.
    Asia Pac J Oncol Nurs. 2018;5:195-200.
    Abstract    

    Abstract available

  56. IM DD, Palazuelos L, Xu L, Molina RL, et al
    A Community-Based Approach to Cervical Cancer Prevention: Lessons Learned in Rural Guatemala.
    Prog Community Health Partnersh. 2018;12:45-54.
    Abstract    

    Abstract available

  57. LUO HX, Du H, Liu ZH, Zhang LJ, et al
    [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Zhonghua Zhong Liu Za Zhi. 2018;40:232-238.
    Abstract    

    Abstract available

  58. LU HJ, Jin PY, Tang Y, Fan SH, et al
    microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-kappaB pathway by targeting E2F1.
    Life Sci. 2018;199:167-178.
    Abstract    

    Abstract available

  59. JIANG Z, Gu M, Liu J, Li H, et al
    Anticancer activity of crocin against cervical carcinoma (HeLa cells): Bioassessment and toxicity evaluation of crocin in male albino rats.
    J Photochem Photobiol B. 2018;180:118-124.
    Abstract    

    Abstract available

  60. JAHROMI BM, Nhu QM, Moawad FJ
    A Rare Cause of Dysphagia - Metastatic Cervical Cancer Causing Esophageal Compression.
    Clin Gastroenterol Hepatol. 2018 Apr 11. pii: S1542-3565(18)30367.
    Abstract    



  61. CHAKRABORTY C, Mitra S, Roychowdhury A, Samadder S, et al
    Deregulation of LIMD1-VHL-HIF-1alpha-VEGF pathway is associated with different stages of cervical cancer.
    Biochem J. 2018 Apr 13. pii: BCJ20170649. doi: 10.1042/BCJ20170649.
    Abstract    

    Abstract available

  62. KHAN MA, Zafaryab M, Hassan SM, Ahmad I, et al
    Physicochemical characterization of curcumin loaded chitosan nanoparticles: Implications in cervical cancer.
    Anticancer Agents Med Chem. 2018 Apr 11. pii: ACAMC-EPUB-89669.
    Abstract    

    Abstract available

  63. LUO C, Fan W, Jiang Y, Zhou S, et al
    Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.
    Med Sci Monit. 2018;24:2197-2209.
    Abstract    

    Abstract available

  64. SCHER N, Castelli J, Depeursinge A, Bourhis J, et al
    ((18)F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
    Cancer Radiother. 2018 Apr 9. pii: S1278-3218(18)30043.
    Abstract    

    Abstract available

  65. LESTYANI NASUTION C, Afiyanti Y, Milanti A
    The relationship of the preexisting anxiety problem with the demographic profile of cervical cancer patients.
    Enferm Clin. 2018;28 Suppl 1:199-202.
    Abstract    

    Abstract available

  66. AMARO-FILHO SM, Pereira Chaves CB, Felix SP, Basto DL, et al
    HPV DNA methylation at the early promoter and E1/E2 integrity: a comparison between HPV16, HPV18 and HPV45 in cervical cancer.
    Papillomavirus Res. 2018 Apr 9. pii: S2405-8521(18)30010.
    Abstract    

    Abstract available

  67. LI X, Tian R, Gao H, Yan F, et al
    Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
    Technol Cancer Res Treat. 2018;17:1533033818767455.
    Abstract    

    Abstract available

  68. BARCHITTA M, Maugeri A, Quattrocchi A, Agrifoglio O, et al
    The Association of Dietary Patterns with High-Risk Human Papillomavirus Infection and Cervical Cancer: A Cross-Sectional Study in Italy.
    Nutrients. 2018;10.
    Abstract    

    Abstract available

  69. ZHAO Y, Huang J, Liu T, He S, et al
    Overexpression of long non-coding RNA RP11-396F22.1 correlates poor prognosis of patients with early-stage cervical cancer.
    Am J Transl Res. 2018;10:684-695.
    Abstract    

    Abstract available

  70. WU Y, Wang A, Zhu B, Huang J, et al
    KIF18B promotes tumor progression through activating the Wnt/beta-catenin pathway in cervical cancer.
    Onco Targets Ther. 2018;11:1707-1720.
    Abstract    

    Abstract available

  71. LI S, Ma YM, Zheng PS, Zhang P, et al
    GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2.
    J Exp Clin Cancer Res. 2018;37:80.
    Abstract    

    Abstract available

  72. YANG L, Wang Y, Shi S, Xie L, et al
    The TNF-alpha-induced expression of miR-130b protects cervical cancer cells from the cytotoxicity of TNF-alpha.
    FEBS Open Bio. 2018;8:614-627.
    Abstract    

    Abstract available

  73. XU HH, Wang K, Feng XJ, Dong SS, et al
    Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
    Oncotarget. 2018;9:15386-15397.
    Abstract    

    Abstract available

  74. OWENGA JA, Nyambedha EO
    Perception of Cervical Cancer Patients on their Financial Challenges in Western Kenya.
    BMC Health Serv Res. 2018;18:261.
    Abstract    

    Abstract available

  75. TIAN S, Chen H, Tan W
    Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
    Biochem Biophys Res Commun. 2018 Apr 6. pii: S0006-291X(18)30805.
    Abstract    

    Abstract available

  76. HWANG J, Hong SS, Kim HJ, Chang YW, et al
    Reduced field-of-view diffusion-weighted magnetic resonance imaging in patients with cervical cancer.
    Br J Radiol. 2018 Apr 9:20170864. doi: 10.1259/bjr.20170864.
    Abstract    

    Abstract available

  77. FARAZI PA, Siahpush M, Michaud TL, Kim J, et al
    Awareness of HPV and Cervical Cancer Prevention Among University Health Sciences Students in Cyprus.
    J Cancer Educ. 2018 Apr 9. pii: 10.1007/s13187-018-1356.
    Abstract    

    Abstract available

  78. WANG F, Shan S, Huo Y, Xie Z, et al
    MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
    Int J Biochem Cell Biol. 2018;99:91-99.
    Abstract    

    Abstract available

  79. SCHUSTER S, Joura E, Kohlberger P
    Natural History of Squamous Intraepithelial Lesions in Pregnancy and Mode of Delivery.
    Anticancer Res. 2018;38:2439-2442.
    Abstract    

    Abstract available

  80. RAMAS V, Mirazo S, Bonilla S, Ruchansky D, et al
    Analysis of human papillomavirus 16 E6, E7 genes and Long Control Region in cervical samples from Uruguayan women.
    Gene. 2018;654:103-109.
    Abstract    

    Abstract available

  81. MAHAJAN S, Pandit-Taskar N
    Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2017 Oct 13. doi: 10.1097/RLU.0000000000001849.
    Abstract    

    Abstract available

  82. BORRULL-GUARDENO J, Dominguez A, Merizalde-Torres MH, Sanchez-Martinez V, et al
    Cervical Cancer Screening in Women With Severe Mental Disorders: An Approach to the Spanish Context.
    Cancer Nurs. 2018 Apr 19. doi: 10.1097/NCC.0000000000000608.
    Abstract    

    Abstract available

  83. YANG M, Wang M, Li X, Xie Y, et al
    Wnt signaling in cervical cancer?
    J Cancer. 2018;9:1277-1286.
    Abstract    

    Abstract available

  84. AVERBACH S, Silverberg MJ, Leyden W, Smith-McCune K, et al
    Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
    Contraception. 2018 Apr 16. pii: S0010-7824(18)30144.
    Abstract    

    Abstract available

  85. LI P, Hu J, Zhang Y, Li J, et al
    [miR-182 promotes cell proliferation of cervical cancer cells by targeting adenomatous polyposis coli (APC) gene].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018;34:148-153.
    Abstract    

    Abstract available

  86. MARKOVIC-DENIC L, Djuric O, Maksimovic N, Popovac S, et al
    Effects of Human Papillomavirus Awareness and Knowledge on Psychological State of Women Referred to Cervical Cancer Screening.
    J Low Genit Tract Dis. 2018 Apr 19. doi: 10.1097/LGT.0000000000000397.
    Abstract    

    Abstract available

  87. RERUCHA CM, Caro RJ, Wheeler VL
    Cervical Cancer Screening.
    Am Fam Physician. 2018;97:441-448.
    Abstract    

    Abstract available

  88. WIPPERMAN J, Neil T, Williams T
    Cervical Cancer: Evaluation and Management.
    Am Fam Physician. 2018;97:449-454.
    Abstract    

    Abstract available

  89. VAZQUEZ-VICENTE D, Fernandez Del Bas B, Garcia Villayzan J, Di Fiore HA, et al
    Laparoscopic paraaortic surgical staging in locally advanced cervical cancer: a single-center experience.
    Clin Transl Oncol. 2018 Apr 18. pii: 10.1007/s12094-018-1878.
    Abstract    

    Abstract available

  90. XIA L, Su X, Shen J, Meng Q, et al
    ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis.
    Cancer Manag Res. 2018;10:663-670.
    Abstract    

    Abstract available

  91. CHOI KH, Kim JY, Lee DS, Lee YH, et al
    Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
    Medicine (Baltimore). 2018;97:e0517.
    Abstract    

    Abstract available

  92. TANAKA T, Sasaki S, Tsuchihashi H, Terai Y, et al
    Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
    Medicine (Baltimore). 2018;97:e0410.
    Abstract    

    Abstract available

  93. BARDAJI A, Mindu C, Augusto OJ, Casellas A, et al
    Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.
    Papillomavirus Res. 2018 Apr 14. pii: S2405-8521(17)30085.
    Abstract    

    Abstract available

  94. XIAO H, Yu L, Li F, Wang H, et al
    MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer.
    Cell Biol Int. 2018 Apr 16. doi: 10.1002/cbin.10974.
    Abstract    

    Abstract available

  95. WU D, Zhang J, Fan P, Li H, et al
    Methylation in the promoter regions of WT1, NKX6-1 and DBC1 genes in cervical cancer tissues of Uygur women in Xinjiang.
    Genet Mol Biol. 2018;41:9-17.
    Abstract    

    Abstract available

  96. LI W, Sun D, Li N, Shen Y, et al
    Therapy of cervical cancer using (131)I-labeled nanoparticles.
    J Int Med Res. 2018 Jan 1:300060518761787. doi: 10.1177/0300060518761787.
    Abstract    

    Abstract available

  97. CHENG Y, Jiang S, Yuan J, Liu J, et al
    Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
    Gynecol Endocrinol. 2018 Apr 16:1-6. doi: 10.1080/09513590.2018.1458304.
    Abstract    

    Abstract available

  98. VASEGHI G, Sharifi M, Dana N, Ghasemi A, et al
    Cytotoxicity of Sargassum angustifolium Partitions against Breast and Cervical Cancer Cell Lines.
    Adv Biomed Res. 2018;7:43.
    Abstract    

    Abstract available

  99. FAN Y, Shen Z
    The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Pathol Res Pract. 2018 Feb 11. pii: S0344-0338(17)31184.
    Abstract    

    Abstract available

  100. BADIAL RM, Dias MC, Stuqui B, Melli PPDS, et al
    Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infection.
    Medicine (Baltimore). 2018;97:e9545.
    Abstract    

    Abstract available

  101. MOON JY, Song IC, Ko YB, Lee HJ, et al
    The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer.
    Medicine (Baltimore). 2018;97:e0340.
    Abstract    

    Abstract available

  102. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    Abstract    



  103. LIANG D, Li DJ, Shi J, Zhang YC, et al
    [Trend of cancer mortality in Hebei province, 1973-2013].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:35-39.
    Abstract    

    Abstract available

  104. MIRANDA S, Chaignot C, Collin C, Dray-Spira R, et al
    Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Vaccine. 2017 Jul 24. pii: S0264-410X(17)30807.
    Abstract    

    Abstract available

  105. KORNIDES ML, Garrell JM, Gilkey MB
    Content of web-based continuing medical education about HPV vaccination.
    Vaccine. 2017 Jul 22. pii: S0264-410X(17)30946.
    Abstract    

    Abstract available

  106. GU Y, Wei M, Wang D, Li Z, et al
    Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30881.
    Abstract    

    Abstract available

  107. UMULISA MC, Franceschi S, Baussano I, Tenet V, et al
    Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.
    BMC Womens Health. 2018;18:59.
    Abstract    

    Abstract available

  108. SINGHAKUM N, Laiwejpithaya S, Chaopotong P
    Digital Cervicography by Simply Portable Device as an Alternative Test for Cervical Cancer Screening in Rural Area of Thailand
    Asian Pac J Cancer Prev. 2018;19:1145-1149.
    Abstract    

    Abstract available

  109. ENDARTI D, Satibi S, Kristina SA, Farida MA, et al
    Knowledge, Perception, and Acceptance of HPV Vaccination and Screening for Cervical Cancer among Women in Yogyakarta Province, Indonesia
    Asian Pac J Cancer Prev. 2018;19:1105-1111.
    Abstract    

    Abstract available

  110. AKRAM HUSAIN RS, Rajakeerthana R, Sreevalsan A, Prema Jayaprasad P, et al
    Prevalence of human papilloma virus with risk of cervical cancer among south Indian women: A genotypic study with meta-analysis and molecular dynamics of HPV E6 oncoprotein.
    Infect Genet Evol. 2018 Apr 23. pii: S1567-1348(18)30208.
    Abstract    

    Abstract available

  111. PRATTE MA, Griffin A, Ogazi C, Yurasevecz S, et al
    Racial/Ethnic Disparities in Cervical Cancer Screening Services Among Contractors of the Connecticut Breast and Cervical Cancer Early Detection Program.
    Health Equity. 2018;2:30-36.
    Abstract    

    Abstract available

  112. MARITA A, Ordeanu C, Rancea A, Nicolae T, et al
    Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    J Med Life. 2018;11:42-50.
    Abstract    

    Abstract available

  113. SAEI GHARE NAZ M, Kariman N, Ebadi A, Ozgoli G, et al
    Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review
    Asian Pac J Cancer Prev. 2018;19:875-884.
    Abstract    

    Abstract available

  114. CZERNIAK B, Olszewska-Slonina D
    Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer.
    Contemp Oncol (Pozn). 2018;22:1-7.
    Abstract    

    Abstract available

  115. SUN H, Huang K, Tang F, Li X, et al
    Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.
    Sci Rep. 2018;8:6443.
    Abstract    

    Abstract available

  116. ZAGHLOUL AS, El-Minawi AM, ElKordy MA, Younes AK, et al
    First experience of the Egyptian National Cancer Institute using the robot-assisted laparoscopic approach in radical hysterectomies for cervical cancer.
    J Egypt Natl Canc Inst. 2018 Apr 21. pii: S1110-0362(18)30022.
    Abstract    

    Abstract available

  117. SINGH S, Gupta M, Seam RK, Changotra H, et al
    E2F1 genetic variants and risk of cervical cancer in Indian women.
    Int J Biol Markers. 2018 Apr 1:1724600818768459. doi: 10.1177/1724600818768459.
    Abstract    

    Abstract available

  118. EJEGOD DM, Pedersen H, Alzua GP, Pedersen C, et al
    Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening.
    Papillomavirus Res. 2018 Apr 21. pii: S2405-8521(18)30008.
    Abstract    

    Abstract available

  119. MA TT, Zhou LQ, Xia JH, Shen Y, et al
    LncRNA PCAT-1 regulates the proliferation, metastasis and invasion of cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2018;22:1907-1913.
    Abstract    

    Abstract available

  120. CAI N, Hu L, Xie Y, Gao JH, et al
    MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-beta receptor 2.
    Eur Rev Med Pharmacol Sci. 2018;22:1899-1906.
    Abstract    

    Abstract available

  121. WANG F, Tan WH, Liu W, Jin YX, et al
    Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Eur Rev Med Pharmacol Sci. 2018;22:1891-1898.
    Abstract    

    Abstract available

  122. GUPTA S, Palmer C, Bik EM, Cardenas JP, et al
    Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
    Front Public Health. 2018;6:77.
    Abstract    

    Abstract available

  123. DIAZ M, Morina D, Rodriguez-Sales V, Ibanez R, et al
    Moving towards an organized cervical cancer screening: costs and impact.
    Eur J Public Health. 2018 Apr 18. pii: 4976520. doi: 10.1093.
    Abstract    

    Abstract available

  124. ISONO-NAKATA R, Tsubamoto H, Ueda T, Inoue K, et al
    Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases.
    Gynecol Oncol Rep. 2018;24:57-60.
    Abstract    

    Abstract available

  125. CHEN Z, Han Y, Song C, Wei H, et al
    Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer.
    Oncotarget. 2017;9:17141-17148.
    Abstract    

    Abstract available

  126. OZAKI D, Miyazawa M, Habano Y, Kawashima M, et al
    [Dose Distribution Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74:354-361.
    Abstract    

    Abstract available

  127. SHAHID N, Craig T, Westerland M, Ashworth A, et al
    Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.
    Brachytherapy. 2018 Apr 19. pii: S1538-4721(18)30085.
    Abstract    

    Abstract available

  128. RODRIGUEZ-ESQUIVEL M, Rosales J, Castro R, Apresa-Garcia T, et al
    Volatolome of the Female Genitourinary Area: Toward the Metabolome of Cervical Cancer.
    Arch Med Res. 2018 Apr 19. pii: S0188-4409(18)30103.
    Abstract    

    Abstract available

  129. GOLFETTO L, Alves EV, Martins TR, Sincero TCM, et al
    PCR-RFLP assay as an option for primary HPV test.
    Braz J Med Biol Res. 2018;51:e7098.
    Abstract    

    Abstract available

  130. YOUNG G
    A nurse-led cervical screening clinic in primary care.
    Rev Infirm. 2018;67:47-48.
    Abstract    

    Abstract available

  131. ELGERT PA, Yee-Chang M, Simsir A
    Cytomegalovirus (CMV) in cervical cancer screening tests: A series of 8 cases and review of the literature.
    Diagn Cytopathol. 2018 Apr 26. doi: 10.1002/dc.23951.
    Abstract    

    Abstract available

  132. DOCKERY LE, Motwani A, Ding K, Doescher M, et al
    Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.
    Gynecol Oncol. 2018;149:89-92.
    Abstract    

    Abstract available

  133. HAGOPIAN GS, Lieber M, Dottino PR, Margaret Kemeny M, et al
    The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York.
    Gynecol Oncol. 2018;149:63-69.
    Abstract    

    Abstract available

  134. RAMEY SJ, Asher D, Kwon D, Ahmed AA, et al
    Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Gynecol Oncol. 2018;149:53-62.
    Abstract    

    Abstract available

  135. STAPLES JN, Wong MS, Rimel BJ
    An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.
    Gynecol Oncol. 2018;149:101-105.
    Abstract    

    Abstract available

  136. CHEN L, Luan S, Xia B, Liu Y, et al
    Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30070.
    Abstract    

    Abstract available

  137. EL-ZEIN M, Bouten S, Louvanto K, Gilbert L, et al
    Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    Gynecol Oncol. 2018 Apr 17. pii: S0090-8258(18)30274.
    Abstract    

    Abstract available

  138. MINION LE, Tewari KS
    Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
    Gynecol Oncol. 2018;148:609-621.
    Abstract    

    Abstract available

  139. MATODA M, Takeshima N, Michimae H, Iwata T, et al
    Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
    Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30286.
    Abstract    

    Abstract available

  140. KELLEN E, Benoy I, Vanden Broeck D, Martens P, et al
    A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31391.
    Abstract    

    Abstract available

  141. DE STROOPER LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, et al
    Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31539.
    Abstract    

    Abstract available

  142. DERKS M, van der Velden J, de Kroon CD, Nijman HW, et al
    Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period.
    Int J Gynecol Cancer. 2018 Mar 27. doi: 10.1097/IGC.0000000000001228.
    Abstract    

    Abstract available

  143. LI P, Zhang R, Nie Z, Long M, et al
    Comparison of Nedaplatin- and Cisplatin-Based Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer Patients: A Propensity Score Analysis.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001265.
    Abstract    

    Abstract available

  144. WELK B, Wallis C, D'Souza D, McGee J, et al
    A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001266.
    Abstract    

    Abstract available

  145. KOJIMA A, Shimada M, Mikami Y, Nagao S, et al
    Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
    Int J Gynecol Cancer. 2018;28:99-106.
    Abstract    

    Abstract available

  146. HOU WH, Schultheiss TE, Wong JY, Wakabayashi MT, et al
    Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Int J Gynecol Cancer. 2018;28:188-193.
    Abstract    

    Abstract available

  147. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2018;28:641-655.
    Abstract    

    Abstract available

  148. GROVER S, Bvochora-Nsingo M, Yeager A, Chiyapo S, et al
    Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
    Int J Radiat Oncol Biol Phys. 2018;101:201-210.
    Abstract    

    Abstract available

  149. HAN K, Shek T, Vines D, Driscoll B, et al
    Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with (18)F-Fluoroazomyin Arabinoside.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30329.
    Abstract    

    Abstract available

  150. PFAENDLER KS, Chang J, Ziogas A, Bristow RE, et al
    Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002591.
    Abstract    

    Abstract available

  151. HU Q, Song J, Ding B, Cui Y, et al
    miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6391.
    Abstract    

    Abstract available

  152. CHEN Y, Zhuang H, Chen X, Shi Z, et al
    Spermidineinduced growth inhibition and apoptosis via autophagic activation in cervical cancer.
    Oncol Rep. 2018 Apr 18. doi: 10.3892/or.2018.6377.
    Abstract    

    Abstract available

  153. NAJJARI JAMAL D, Potter R, Haie-Meder C, Lindegaard JC, et al
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Radiother Oncol. 2018 Apr 6. pii: S0167-8140(18)30170.
    Abstract    

    Abstract available

  154. SMET S, Potter R, Haie-Meder C, Lindegaard JC, et al
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
    Radiother Oncol. 2018 Apr 4. pii: S0167-8140(18)30141.
    Abstract    

    Abstract available

  155. ZACAPALA-GOMEZ AE, Navarro-Tito N, Alarcon-Romero LDC, Ortuno-Pineda C, et al
    Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    BMC Cancer. 2018;18:349.
    Abstract    

    Abstract available

  156. JAVED S, Sharma BK, Sood S, Sharma S, et al
    Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer.
    BMC Cancer. 2018;18:357.
    Abstract    

    Abstract available

  157. YANG Y, Moser MAJ, Zhang E, Zhang W, et al
    Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro.
    PLoS One. 2018;13:e0195561.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;